SEC Form 4 · accession 0001193125-26-266435
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Mahony
Director
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 9:49 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001579428
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jun 8, 2026 | M | 1,429 | — | A | 1,429 | D | |
| Common StockF4 | Jun 9, 2026 | S | 300 | $237.21 | D | 1,129 | D | |
| Common StockF4 | Jun 10, 2026 | S | 300 | $246.18 | D | 829 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Jun 8, 2026 | M | 1,429 | D | — | — | Common Stock | 1,429 | 0 | D |
Explanation of responses
- F1Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant.
- F3Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.
- F4These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.